The role of the HGF/c-MET pathway in PSC-cancer cell interactions was determined by performing indirect co-culture experiments and assessing the effects of PSC secretions on cancer cell functions in the presence or absence of HGF/c-MET inhibitors and/or gemcitabine. Here, MET is linked to cancer.